SonALAsense was founded to create hope in the face of despair with Sonodynamic Therapy (SDT), a non-invasive way to treat and eradicate deadly cancers like High-Grade Gliomas (HGG) that typically require debilitating brain surgery that often leads to tumor recurrence.
SDT uses SONALA-001 and an MR-guided focused ultrasound device, a true drug-device combination. Both drug and device are required for a therapeutic effect. The phase 0/1 clinical trial in Recurrent HGG
gives us hope as we pursue our mission.